BACKGROUND: The higher incidence of acute lymphoblastic leukemia (ALL) among Hispanic children relative to that in other racial/ethnic groups is well-known. We evaluated the incidence patterns of ALL in adults. METHODS: We analyzed the incidence patterns of ALL (International Classification of Diseases for Oncology 3 codes 9835-9837) among all patients diagnosed from 1988 to 2004 in California using data from the California Cancer Registry to determine whether adult Hispanics also had higher incidence rates of ALL compared with non-Hispanic Whites (Whites). Age-adjusted incidence rates (AAIR), incidence rate ratios (IRR), and 5-year survival rates were obtained using SEER*Stat. AAIRs of other leukemia subtypes and IRRs relative to non-Hispanic Whites were also examined as references for ALL. RESULTS: AAIRs of ALL in Hispanic males and females ages 20 to 54 years were higher compared with those in White males and females (IRR, 1.99; 95% confidence interval, 1.74-2.28 and IRR, 1.91; 95% confidence interval, 1.60-2.25, respectively). A higher AAIR of ALL was also observed among older (55+ years) Hispanic females (IRR, 1.84; 95% confidence interval, 1.52-2.21), but not in males (IRR, 1.07; 95% confidence interval, 0.84-1.34). Among Hispanics, low socioeconomic status was associated with a higher AAIR compared with high/middle socioeconomic status (IRR, 1.33; 95% confidence interval, 1.04-1.70). The respective 5-year survival rates among ALL patients were 38% and 30% for Whites and Hispanics ages 20 to 54 years, and 8% and 12% for patients 55 years of age or older. Compared with other racial/ethnic groups, Hispanics did not have an increased IRR of the other major leukemia subtypes. CONCLUSION: Hispanics experience a higher incidence of ALL throughout life, but not other subtypes.
BACKGROUND: The higher incidence of acute lymphoblastic leukemia (ALL) among Hispanic children relative to that in other racial/ethnic groups is well-known. We evaluated the incidence patterns of ALL in adults. METHODS: We analyzed the incidence patterns of ALL (International Classification of Diseases for Oncology 3 codes 9835-9837) among all patients diagnosed from 1988 to 2004 in California using data from the California Cancer Registry to determine whether adult Hispanics also had higher incidence rates of ALL compared with non-Hispanic Whites (Whites). Age-adjusted incidence rates (AAIR), incidence rate ratios (IRR), and 5-year survival rates were obtained using SEER*Stat. AAIRs of other leukemia subtypes and IRRs relative to non-Hispanic Whites were also examined as references for ALL. RESULTS: AAIRs of ALL in Hispanic males and females ages 20 to 54 years were higher compared with those in White males and females (IRR, 1.99; 95% confidence interval, 1.74-2.28 and IRR, 1.91; 95% confidence interval, 1.60-2.25, respectively). A higher AAIR of ALL was also observed among older (55+ years) Hispanic females (IRR, 1.84; 95% confidence interval, 1.52-2.21), but not in males (IRR, 1.07; 95% confidence interval, 0.84-1.34). Among Hispanics, low socioeconomic status was associated with a higher AAIR compared with high/middle socioeconomic status (IRR, 1.33; 95% confidence interval, 1.04-1.70). The respective 5-year survival rates among ALL patients were 38% and 30% for Whites and Hispanics ages 20 to 54 years, and 8% and 12% for patients 55 years of age or older. Compared with other racial/ethnic groups, Hispanics did not have an increased IRR of the other major leukemia subtypes. CONCLUSION: Hispanics experience a higher incidence of ALL throughout life, but not other subtypes.
Authors: Martyn T Smith; Cliona M McHale; Joseph L Wiemels; Luoping Zhang; John K Wiencke; Shichun Zheng; Laura Gunn; Christine F Skibola; Xiaomei Ma; Patricia A Buffler Journal: Toxicol Appl Pharmacol Date: 2005-08-07 Impact factor: 4.219
Authors: C F Skibola; M T Smith; E Kane; E Roman; S Rollinson; R A Cartwright; G Morgan Journal: Proc Natl Acad Sci U S A Date: 1999-10-26 Impact factor: 11.205
Authors: Christine F Skibola; Martyn T Smith; Alan Hubbard; Barry Shane; Abby C Roberts; Graham R Law; Sara Rollinson; Eve Roman; Raymond A Cartwright; Gareth J Morgan Journal: Blood Date: 2002-05-15 Impact factor: 22.113
Authors: Christina A Clarke; Sally L Glaser; Theresa H M Keegan; Antoinette Stroup Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-06 Impact factor: 4.254
Authors: Quan-He Yang; Lorenzo D Botto; Margaret Gallagher; J M Friedman; Christopher L Sanders; Deborah Koontz; Stanimila Nikolova; J David Erickson; Karen Steinberg Journal: Am J Clin Nutr Date: 2008-07 Impact factor: 7.045
Authors: Jeremy Sharib; Andrew Horvai; Florette K Gray Hazard; Heike Daldrup-Link; Robert Goldsby; Neyssa Marina; Steven G DuBois Journal: Pediatr Blood Cancer Date: 2013-08-23 Impact factor: 3.167
Authors: H Alachkar; N Fulton; B Sanford; G Malnassy; M Mutonga; R A Larson; C D Bloomfield; G Marcucci; Y Nakamura; W Stock Journal: Pharmacogenomics J Date: 2016-03-29 Impact factor: 3.550
Authors: Ibrahim Aldoss; Tracey Stiller; Ni-Chun Tsai; Joo Y Song; Thai Cao; N Achini Bandara; Amandeep Salhotra; Samer Khaled; Ahmed Aribi; Monzr M Al Malki; Matthew Mei; Haris Ali; Ricardo Spielberger; Margaret O'Donnell; David Snyder; Thomas Slavin; Ryotaro Nakamura; Anthony S Stein; Stephen J Forman; Guido Marcucci; Vinod Pullarkat Journal: Haematologica Date: 2018-06-14 Impact factor: 9.941